Navigation Links
Profarma's Gross Revenues Reached R$ 702.6 Million in the 1st Quarter 2008, a 26.5% Growth Over the Same Period Last Year

RIO DE JANEIRO, Brazil, May 5 /PRNewswire-FirstCall/ -- One of Brazil's leading distributors of pharmaceutical products, Profarma Distribuidora de Produtos Farmaceuticos S.A. ("Profarma" or the "Company") (Bovespa: PFRM3) has just announced its results for the first quarter of 2008 (1Q08).


-- Growth of 26.5% in consolidated Gross Revenue when compared to the same

period of the previous year, reaching R$ 702.6 million.

-- Profarma's market share reaches 11.8% in the 1Q08, 1.1 percentage

points above the share reached in the same period of the previous year.

-- The adjusted EBITDA was of R$ 18.6 million, a 24.0% growth when

compared to the R$ 15.0 million posted in the 1Q07.

-- Increase in the service level, reaching 91.2% in the 1Q08, a 1.2

percentage points growth in relation to the 1Q07 and 0.3 percentage

points in relation to the 4Q07.

-- Annual price increase that occurred in March 31st was of 3.1% in

average, 50% higher than the previous year.



Tuesday, May, 06th, 2008.

10:00 a.m. (Brazil)

09:00 a.m. (NY)

Telephone: +55 (11) 2188-0188

Replay: +55 (11) 2188-0188



Tuesday, May, 06th, 2008.

12:00 p.m. (Brazil)

11:00 a.m. (NY)

Telephone: +1 (973) 935-8893

Replay: +1 (706) 645-9291

Code: 43748460

SOURCE Profarma Distribuidora de Produtos Farmaceuticos S.A.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Renowned ENT Specialist, Dr. Murray Grossan, Announces Medical Breakthrough on Snoring at PRI-MED Convention in Anaheim on May 15-17
2. Woodrin Woody Grossman Appointed to MedCaths Board of Directors
3. China Nepstar Chain Drugstore Reports 231.5% Increase in Net Income and Record Gross Margin of 48.5% for Fourth Quarter 2007
4. Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09
5. Profarmas Gross Revenues Reached R$ 698.2 Million in the 3rd Quarter 2007, a 31.9% Growth Over the Same Period Last Year and Net Income Rose by 94.9%, Respectively
6. inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
7. Grosse Pointes Cottage Hospital Joins Henry Ford Health System
8. Michael Moores SiCKO Becomes the Third Highest Grossing Documentary of All Time Surpassing An Inconvenient Truth
9. Precyse Solutions Launches Clinical Documentation Improvement Program to Assist Hospitals in Accelerating Revenues
10. Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007
11. MEDRAD(R) Revenues Grow 10 Percent in 2007
Post Your Comments:
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along ... updates for the primary prevention of cardiovascular diseases during the 15th Annual ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional women, ... towards gender equality at their inaugural Summit in New York City in June. The ... social audience of over 3 million. To watch the Mobilize Women video, click ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017  DarioHealth ... and big data solutions, today announced that its MyDario product is expected ... local TV listings for when The Dr. Oz Show airs in your ... The nine-time Emmy ... ...
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing a ... targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek , ...
Breaking Medicine Technology: